ADVERTISEMENT
Advertise

Content

List volumes - List articles in this issue

Letter to the Editor

Etanercept-induced Clinical Remission of Type II Pityriasis Rubra Pilaris With Rheumatoid Arthritis

doi: 10.2340/00015555-1367

Abstract:

Abstract is missing (Letter)

Authors:

Jong Hoon Kim, Min-Chan Park, Soo-Chan Kim

References

  • Müller H, Gattringer C, Zelger B, Höpfl R, Eisendle K. Infliximab monotherapy as first-line treatment for adult-onset pityriasis rubra pilaris: case report and review of the literature on biologic therapy. J Am Acad Dermatol 2008; 59: S65–70.
  • Garcovich S, Di Giampetruzzi AR, Antonelli G, Garcovich A, Didona B. Treatment of refractory adult-onset pityriasis rubra pilaris with TNF-alpha antagonists: a case series. J Eur Acad Dermatol Venereol 2010; 24: 881–884.
  • Davis KF, Wu J, Murase JE, Rosenberg FR, Sorenson EP, Meshkinpour A. Clinical improvement of pityriasis rubra pilaris with combination etanercept and acitretin therapy. Arch Dermatol 2007; 143: 1597–1599.
  • Cox V, Lesesky EB, Garcia BD, O’Grady TC. Treatment of juvenile pityriasis rubra pilaris with etanercept. J Am Acad Dermatol 2008; 59: S113–114.
  • Seckin D, Tula E, Ergun T. Successful use of etanercept in type I pityriasis rubra pilaris. Br J Dermatol 2008; 158: 642–644.
  • Guedes R, Leite L. Therapeutic hotline. Treatment of pityriasis rubra pilaris with etanercept. Dermatol Ther 2011; 24: 285–286.
  • Chan H, Liu FT, Naguwa S. A review of pityriasis rubra pilaris and rheumatologic associations. Clin Dev Immunol 2004; 11: 57–60.
  • Mazza J, Rossi A, Weinberg JM. Innovative uses of tumor necrosis factor alpha inhibitors. Dermatol Clin 2010; 28: 559–575.
  • Related articles

    There are no related articles.


    Share with your friends





    Actions


    Abstract

    Full text

    PDF

    Supplementary


    There is no supplementary for this article.

    Print information


    Volume 92, Issue 4

    DOI: 10.2340/00015555-1367

    Pages: 399-400

    View at PubMed